August 12th 2025, 9:00pm
I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for those facing cancer.
August 12th 2025, 8:00pm
A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.
August 12th 2025, 7:00pm
Long-term follow-up data from the phase 3 MANIFEST 2 clinical trial have been revealed.
August 12th 2025, 5:03pm
Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like heart disease and obesity.
August 12th 2025, 4:00pm
I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and strength to keep fighting.
August 12th 2025, 3:00pm
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date.
August 12th 2025, 1:00pm
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance of hisloved ones.
August 11th 2025, 9:00pm
Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and speaking out against hatred.
August 11th 2025, 8:00pm
In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’
August 11th 2025, 7:00pm
It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect real-world patient populations.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC